Impact of humanised isolation and culture conditions on stemness and osteogenic potential of bone marrow derived mesenchymal stromal cells

被引:10
|
作者
Suliman, Salwa [1 ]
Ali, Hassan R. W. [1 ]
Karlsen, Tommy A. [2 ]
Amiaud, Jerome [3 ]
Mohamed-Ahmed, Samih [1 ]
Layrolle, Pierre [3 ]
Costea, Daniela E. [4 ,5 ,6 ]
Brinchmann, Jan E. [2 ,7 ]
Mustafa, Kamal [1 ]
机构
[1] Univ Bergen, Ctr Clin Dent Res, Dept Clin Dent, Bergen, Norway
[2] Oslo Univ Hosp, Dept Immunol, Norwegian Ctr Stem Cell Res, Rikshosp, Oslo, Norway
[3] Univ Nantes, Fac Med, Lab Bone Sarcomas & Remodeling Calcified Tissues, INSERM,UMR 1238,PHY OS, Nantes, France
[4] Univ Bergen, Dept Clin Med, Gade Lab Pathol, Bergen, Norway
[5] Haukeland Hosp, Dept Pathol, Bergen, Norway
[6] Univ Bergen, Ctr Canc Biomarkers, Bergen, Norway
[7] Univ Oslo, Fac Med, Dept Mol Med, Oslo, Norway
基金
欧盟地平线“2020”;
关键词
FETAL BOVINE SERUM; HUMAN PLATELET LYSATE; IN-VITRO EXPANSION; GENE-EXPRESSION; GROWTH-FACTOR; ADIPOSE-TISSUE; DIFFERENTIATION; PROLIFERATION; SUBSTITUTE; CRYOPRESERVATION;
D O I
10.1038/s41598-019-52442-9
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Therapeutic potential of human bone marrow stromal/stem cells (hBMSC) must be developed using well defined xenogenic-free conditions. hBMSC were isolated from healthy donors (n = 3) using different isolation and expansion methods. Donor I was isolated and expanded by either bone marrow directly seeded and cells expanded in 10% AB human serum (AB) + 5 ng/ml fibroblast growth factor-2 (FGF2) [Direct(AB + FGF(low))] or Ammonium-Chloride-Potassium Lysing Buffer was used before the cells were expanded in 10% AB + 5 ng/ml FGF-2 [ACK(AB + FGF(low))] or Lymphoprep density gradient medium was used before the cells were expanded in 10% AB + 5 ng/ml FGF2 [Lympho(AB + FGF(low))] or bone marrow directly seeded and cells expanded in 10% pooled platelet lysate plasma (PL) + heparin (2 I/U/mL) [Direct(PL)]. Groups for donors II and III were: Direct(AB + FGF(low)) or 10% AB + 10 ng/ml FGF2 [Direct(AB + FGF(high))] or Direct(PL). HBMSCs were assessed for viability, multi-potency, osteogenic, inflammatory response and replicative senescence in vitro after 1 and 3 weeks. Pre-selected culture conditions, Direct(AB + FGF(high)) or Direct(PL), were seeded on biphasic calcium phosphate granules and subcutaneously implanted in NOD/SCID mice. After 1 and 11 weeks, explants were analysed for inflammatory and osteogenic response at gene level and histologically. To identify implanted human cells, in situ hybridisation was performed. hBMSC from all conditions showed in vitro multi-lineage potency. hBMSCs expanded in PL expressed stemness markers in vitro at significantly higher levels. Generally, cells expanded in AB + FGF2 conditions expressed higher osteogenic markers after 1 week both in vitro and in vivo. After 11 weeks in vivo, Direct(AB + FGF(high)) formed mature ectopic bone, compared to immature mineralised tissues formed by Direct(PL) implants. Mouse responses showed a significant upregulation of IL-1 alpha and IL-1 beta expression in Direct(PL). After 1 week, human cells were observed in both groups and after 11 weeks in Direct(AB + FGF(high)) only. To conclude, results showed a significant effect of the isolation methods and demonstrated a relatively consistent pattern of efficacy from all donors. A tendency of hBMSC expanded in PL to retain a more stem-like phenotype elucidates their delayed differentiation and different inflammatory expressions.
引用
收藏
页数:18
相关论文
共 50 条
  • [31] Prolonged in vitro expansion partially affects phenotypic features and osteogenic potential of ovine amniotic fluid-derived mesenchymal stromal cells
    Colosimo, Alessia
    Russo, Valentina
    Mauro, Annunziata
    Curini, Valentina
    Marchisio, Marco
    Bernabo, Nicola
    Alfonsi, Melissa
    Mattioli, Mauro
    Barboni, Barbara
    CYTOTHERAPY, 2013, 15 (08) : 930 - 950
  • [32] Ascorbic Acid Enhances Adipogenesis of Bone Marrow-Derived Mesenchymal Stromal Cells
    Weiser, Barbara
    Sommer, Florian
    Neubauer, Markus
    Seitz, Annina
    Tessmar, Joerg
    Goepferich, Achim
    Blunk, Torsten
    CELLS TISSUES ORGANS, 2009, 189 (06) : 373 - 381
  • [33] Bone marrow-derived mesenchymal stromal cells differ in their attachment to fibronectin-derived peptides from term placenta-derived mesenchymal stromal cells
    Maerz, Jan K.
    Roncoroni, Lorenzo P.
    Goldeck, David
    Abruzzese, Tanja
    Kalbacher, Hubert
    Rolauffs, Bernd
    DeZwart, Peter
    Nieselt, Kay
    Hart, Melanie L.
    Klein, Gerd
    Aicher, Wilhelm K.
    STEM CELL RESEARCH & THERAPY, 2016, 7
  • [34] Inhibition of osteogenic and adipogenic potential in bone marrow-derived mesenchymal stem cells under osteoporosis
    Huang, Tingben
    Yu, Zhou
    Yu, Qiong
    Wang, Ying
    Jiang, Zhiwei
    Wang, Huiming
    Yang, Guoli
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2020, 525 (04) : 902 - 908
  • [35] Characterization of Platelet Lysate Cultured Mesenchymal Stromal Cells and Their Potential Use in Tissue-Engineered Osteogenic Devices for the Treatment of Bone Defects
    Salvade, Agnese
    Della Mina, Pamela
    Gaddi, Diego
    Gatto, Francesca
    Villa, Antonello
    Bigoni, Marco
    Perseghin, Paolo
    Serafini, Marta
    Zatti, Giovanni
    Biondi, Andrea
    Biagi, Ettore
    TISSUE ENGINEERING PART C-METHODS, 2010, 16 (02) : 201 - 214
  • [36] Effect of High BMI on Human Bone Marrow-Derived Mesenchymal Stromal Cells
    Zong, Qiang
    Bundkirchen, Katrin
    Neunaber, Claudia
    Noack, Sandra
    CELL TRANSPLANTATION, 2024, 33
  • [37] A New Approach to Evaluation of Osteogenic Potential of Mesenchymal Stromal Cells
    Ostanin, A. A.
    Petrovskiy, Ya. L.
    Shevela, E. Ya.
    Kurganova, E. V.
    Drobinskaja, A. N.
    Dobryakova, O. B.
    Lisukova, E. V.
    Chernykh, E. R.
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2008, 146 (04) : 534 - 539
  • [38] A robust and reproducible animal serum-free culture method for clinical-grade bone marrow-derived mesenchymal stromal cells
    Laitinen, Anita
    Oja, Sofia
    Kilpinen, Lotta
    Kaartinen, Tanja
    Moller, Johanna
    Laitinen, Saara
    Korhonen, Matti
    Nystedt, Johanna
    CYTOTECHNOLOGY, 2016, 68 (04) : 891 - 906
  • [39] A New Approach to Evaluation of Osteogenic Potential of Mesenchymal Stromal Cells
    A. A. Ostanin
    Ya. L. Petrovskiy
    E. Ya. Shevela
    E. V. Kurganova
    A. N. Drobinskaja
    O. B. Dobryakova
    E. V. Lisukova
    E. R. Chernykh
    Bulletin of Experimental Biology and Medicine, 2008, 146 : 534 - 539
  • [40] Effect of bone marrow-derived mesenchymal stromal cells on hepatoma
    Abd-Allah, Somia H.
    Shalaby, Sally M.
    El-Shal, Amal S.
    Abd Elkader, Eman
    Hussein, Samia
    Emam, Emad
    Mazen, Nehad F.
    El Kateb, Mohammed
    Atfy, Mha
    CYTOTHERAPY, 2014, 16 (09) : 1197 - 1206